chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PATIENTS IS A DOCTOR   BILATERAL PROFUSE  RASH (CHICKENPOX LIKE BUT NO BLISTERS OR WEEPING) TO NECK , ARMS, ARMPITS, CHEST - PT STATES THAT HE FEELS THE RASH IS NOW STARTING TO IMPROVE NO NERVE PAIN
Did you/the patient previously receive a COVID-19 Vaccine?: Yes; Did you/the patient previously receive a COVID-19 Vaccine?: Yes; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An 86-year-old male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "HTN" (unspecified if ongoing), notes: Other medical history: HTN. Concomitant medication(s) included: NORVASC. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Did you/the patient previously receive a COVID-19 Vaccine?: Yes". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: It was reported that patient received the vaccine. Received other medication in 2 weeks with Norvasc. It was reported that patient take COVID 19 Treatment on 23May2022 to 27May2022 via Oral Administrator route. Vaccine dose number unknown.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Hyperglycemia/ they experiences sugar going out of control; This affected their normal activities of daily living, they could not excursive; Were tired; This spontaneous case was reported by a patient and describes the occurrence of HYPERGLYCAEMIA (Hyperglycemia/ they experiences sugar going out of control), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (This affected their normal activities of daily living, they could not excursive) and FATIGUE (Were tired) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 057m21A, 012L20A, 016M20A and 012F21A) for COVID-19 vaccination.     It was reported that patient never had COVID positive test or diagnosis.  Concurrent medical conditions included Type 2 diabetes mellitus, Allergy NOS and Hypertension. Concomitant products included LISINOPRIL, APIXABAN (ELIQUIS), ATORVASTATIN, ASPIRIN [ACETYLSALICYLIC ACID], CHOLECALCIFEROL, DULOXETINE, PANTOPRAZOLE, FAMOTIDINE, BUSPIRONE, CARVEDILOL, DULAGLUTIDE (TRULICITY), GLIMEPIRIDE, OMEGA-3 FATTY ACIDS (KRILL OMEGA RED OIL), UBIDECARENONE (COQ10 [UBIDECARENONE]), MULTIVITAMINS [VITAMINS NOS], ATORVASTATIN and LEVOFLOXACIN (LEXA) for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERGLYCAEMIA (Hyperglycemia/ they experiences sugar going out of control), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (This affected their normal activities of daily living, they could not excursive) and FATIGUE (Were tired). At the time of the report, HYPERGLYCAEMIA (Hyperglycemia/ they experiences sugar going out of control), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (This affected their normal activities of daily living, they could not excursive) and FATIGUE (Were tired) was resolving.            No other vaccines given within 1 month prior to Moderna COVID-19 vaccine. The patient has never experienced a similar event in the past.  No treatment medications were reported.
Headache, NauseaVomiting, Fatigue, Pain at injection site Narrative:
co numbness and tingeling to L arm, unequal hand grasps. co chest heaviness with no difficulty breathing. pt instructed to sit. no rash, redness to site or hives. no inflammation to injection site or redness. ice pack applied to L arm. then co nausea, dizziness, and "seeing spots" no labored breathing,  JVD. pulse 108, bp 140/75. bp retaken at 1140 160/100,60, 16 and non labored after pt lying. 1150 160/90, 88. lungs clear, no wheezes. mother contacted at 1150, obtained permission to call brother in law to bring inhalor. 1220 condition unchanged. glucose 103, Bp 152/88 86 20. Brother arrived, pt used inhalor with no relief. Brother transported to local health care facility. at time of report disposition unknown.
Patient received Moderna full dose 0.5 ml instead of 0.25 ml. I checked the company email and saw where it was approved but not the change in dose. I called Moderna on 10/26 to get information send to my email. I called patient on 10/29 and she stated that she had some diarrhea but probably not related to the vaccine. She feels fine now.
Patient had a brief syncopal event about 1 minute after receiving the vaccine. About 20-25 minutes after the vaccine he had 2 episodes of vomiting. He felt normal within an hour of the vaccine.
(L) upper arm cellulitis - fever, redness at site, achy all over.
After receiving the Pfizer vaccine on Sunday 9/12 I had a headache for two days.  Tues 9/14 I felt my throat hurt a little but I thought it was my allergies.  By Wednesday 9/15 my right side glands were swollen.  I was unable to get an appointment with my Dr or City MD.  By Friday I was unable to swallow.  My lymphnodes were so swollen when I swallowed it was like knives in my throat.  I went to City MD where they diagnosed me with lymhonitis.  I had a rapid covid test and negative for strep plus no fever.  They prescribed antibiotics.  Later on that Friday I was able to get an appointment with my Dr who agreed that my symptoms was a reaction to the vaccine and it was common but at that time I felt so horrible.  I slept the rest of the weekend.  Today Monday 9/20 I feel 80% better.  My glands still hurt and my neck is tender.
had 2nd vaccine March 12, 2021, then next day significant fatigue, March 14 nausea, diarrhea, aches, feverishness,  March 15lightheaded and hypotensive to bp 76 systolic
A non-serious, spontaneous report of nausea has been received from a patient's mother concerning her seven-year-old son subsequent to FLUMIST. The patient's medical history and concomitant medications were not reported. The patient received FLUMIST on 17-Sep-2009. On 18-Sep-2009, the patient had nausea. On the same day, the reporter's dog was also sick. The outcome of the patient's adverse event is unknown.
Right arm knot that's sore when touching, not itching, pt. is applying hydrocortisone cream. Pt is a little red.
On April 7th received Janssen COVID vaccine at pharmacy. On April 13 started developing shortness of breath and dizziness/light headed. Had knee surgery at hospital the 14th on right knee to remove cyst (scheduled surgery). On 15th still short of breath and felt like had cold. Worsening SOB on 16th. On 17 was SOB walking from bathroom. Talked to daughter on phone and she said to go to ER. Went to  ER about 8pm and Was diagnosed with bilateral blood clots in lungs and admitted to step down on heparin drip.  Getting Echo TEE on Monday 19th and bilateral leg ultrasounds today on 18th
Pt received a covid imz, pt stated after about 5 minutes that he felt warm, we went to get him some water and were immediately notified by another pt that he fainted, he hit his head after falling out of the chair, he hit his head but awoke immediately and was coherent. after pt stated that he has anxiety and probably had a panic attack and fainted. there was a small cut on his head but he appeared ok, ambulance arrived at the location and ems gave him an ice pack and checked him out he mentioned that he would see a dr but refused any other treatment from ems
Chills, aches & pain from head to toe, migraine, nausea, dizzy, weak, fatigued, low grade fever, Rash at site of injection, Lymph nodes swollen & painful under arm on the same arm as injection. Felt better on 2/25/21.
pt recv vax 12MAR97 & 26MAR97 pt devel localized inj site rash consisting of two areas of red lumps w/pruritus, one similar small area on stomach, one area under arm;pt denied having any fluid in them;
Seizure of 10 to 30 minutes duration. Taken to ER. Given Dilantin and changed to Tegretol. Still on medication. No seizures since onset.
achy; tired; achy in her shoulders, neck and arms and back; achy in her shoulders, neck and arms and back; achy in her shoulders, neck and arms and back; shooting pains in her calf and feet; regular sore arm; This is a spontaneous report from a contactable consumer (patient). A 78-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EL3249), via an unspecified route of administration, administered in the left arm on 04Feb2021, at 09:00 (at the age of 78 years old) as dose 2, single for COVID-19 immunisation. Medical history included ongoing arthritis (being treated for her shoulder and right arm), high blood pressure, low thyroid, high cholesterol (under control), and factor 5. The patient reported that both of her parents died of cancer. Concomitant medications included high blood pressure medicine (taking for about 3 years), thyroid medicine (has been taking it many years), and cholesterol medicine (taking half of it, has been taking it for about a year). It was reported that the patient did not receive any other vaccines within four weeks prior to vaccination. The patient previously received shingles and flu shot on an unspecified date for immunisation with no side effects. The patient reported that she has had different symptoms from what other people have said. On 04Feb2021, the patient experienced regular sore arm. At 21:00, she experienced achy, tired, achy in her shoulders, neck and arms and back, and shooting pains in her calf and feet. The clinical course was as follows: On 04Feb2021, the patient has had the regular sore arm, tired which was normal. At 21:00, the patient took a paracetamol (TYLENOL) because of the aching in her arm shoulders and back. She said that she normally uses a heating pad because she has arthritis. The patient said that an hour after that she had shooting pains in her calf and feet she thought it was electrical shocks from heating pad, it lasted for about 2.5 hours. She used the heating pad for back. The patient said she was achy in her shoulders, neck and arms and back. The patient was unable to clarify if she has recovered completely or recovered with lasting effects, she said its better but she was still really tired. The patient stated that she got the vaccine at 9:00 and all of the symptoms started at 9pm on 04Feb2021, except for the sore arm, which started earlier. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
1 HOUR AFTER FLUMIST WAS RECEIVED SHE HAD AN URGENT SOFT BOWEL MOVEMENT WITH 2 PEA SIZED BLOOD CLOTS PRESENT AND WATER IN TOILET WAS RED WITH BLOOD AS DESCRIBED BY MOTHER.
Nausea Seen by EMS,  Pt. left in stable condition at 12:06
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 40-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 19Oct2022 as dose number unknown, single (Lot number: GJ3277) at the age of 39 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. The patient had no known allergy. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, suspected covid-19 including Paxlovid from 27Apr2023 to 02May2023.
Assessment and Plan:   Patient with recently diagnosed large B-cell lymphoma (primary mediastinal lymphoma versus gray zone lymphoma).   Admitted for pneumonia and COVID infection with sepsis without organ dysfunction. Patient is status post cycle 1 of DA?R EPOCH?R chemotherapy.  On G-CSF support.  Counts are stable. Agree with aggressive antimicrobial therapy.  Expect counts to decline over the next few days with subsequent recovery.  Continue to monitor. Plan for CT chest next week Friday.     Note Details  Author  (M.D.) File Time 7/7/2023 10:34 AM Author Type Physician Status Signed
Information has been received from a physician concerning an 11 year old (also reported as 8 year old) male who on 14-FEB-2000 was vaccinated with a first dose of MMR II (route, site and lot number not reported). On 06-JAN-2004 he received second dose of MMR II  (route, site and lot number not reported). On 01-JAN-2010 the patient experienced mumps, diagnosed on 03-JAN-2010. The patient was afebrile and had left parotitis. The outcome for mumps was not reported. No further information is available.
He was in a basketball tournament.  After the first game, he had a "stinger feeling in his chest."  During the second game, he felt dizzy and complained of headache.  His physician followed up with a phone call.  I spoke to mom today (7/23).  He is fine.
10 minutes after his vaccination, the patient was sitting with his mother and sister in our waiting room per protocol after a vaccine.  I heard a mom scream while I was giving another patient a vaccine. I ran out with an epipen but he was awake, alert, and breathing normally. I asked what happened and she said he fainted for a second and seized or twitched a little. I did not give him any epinephrine because he was not having any issues breathing and was able to tell me he felt fine. We did call 911 per moms request and they came and checked him out.
Patient took a nap after her vaccine and woke up with shivering and a rectal temp of 101.3
Client reported dizziness and warm feeling "all over" 15 minutes after vaccination.  Care initiated by on site paramedics.  B/P 140/80.  Monitored x30 minutes.  Client reported no further symptoms prior to exiting site.
patient was diaphoretic, fell to the floor from seated without hitting head, very anxious as reported by patient. Patient rested, declined intervention including water, juice, or snack. patient was stable upon leaving
8/3/23 symptoms developed bilateral ears: intense ear pressure and fullness , dull/sharp ear ache, sound sensitivity, intermittent moderate ringing in ears. 9/18/23: Symptoms worsened. Ringing is consistent and louder, pressure/fullness, dull aches, feeling of internal heat, sound sensitivity. Symptoms affecting daily life (I.e., sleep, concentration ).
Patient developed a superficial abscess measuring 2-2.5 cm 4 days after vaccine administration at the injection site of the Pneumococcal conjugate vaccine (right thigh).
really sick; fever of 100.7 F; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (really sick), PYREXIA (fever of 100.7 F) and HEADACHE (Headaches) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 and Foot surgery. Concurrent medical conditions included Drug allergy (Penicillin allergy). Concomitant products included GABAPENTIN for Nerve pain, OMEPRAZOLE for Stomach discomfort.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 16-Feb-2021, the patient experienced VACCINATION COMPLICATION (really sick), PYREXIA (fever of 100.7 F) and HEADACHE (Headaches). On 18-Feb-2021, VACCINATION COMPLICATION (really sick), PYREXIA (fever of 100.7 F) and HEADACHE (Headaches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  Concomitant medication included gabapentin to treat foot nerve pain.
Myalgia, Arthralgia, Chills, body ache, low energy Narrative:
VACCINE "BOOSTER DOSE"  WAS ADMINISTERED EARLIER THAN RECOMMENDED TIME (1 MONTH EARLIER) NO ADVERSE ISSUES, SIGNS/SYMPTOMS NOTED AT THIS TIME
Systemic: Fainting / Unresponsive-Mild, Systemic: Shakiness-Mild, Systemic: Weakness-Mild, Additional Details: After vaccines given, patient lost consciousness/fainted twice, felt weak, was shaking, seizure-like. EMS, patient was assessed all was normal. vital signs normal. He felt better. Per patient, he did not eat yet, NKA, no meds, no past medical history.
On the night of the COVID booster shot, I had severe body aches and had a very high fever (over 103 degrees) through Tuesday, taking tylenol and ibuprofen simultaneously to keep the fever down. Did a telehealth appointment on Monday, was instructed to wait and see. Took an in-home COVID test and the COVID test was negative. The fever resolved after Tuesday, the GI issues and nasal congestion, fatigue, body aches are still lingering. They have stayed at the same intensity. Schedule for doctor's appointed 2/4/2022 to be re-evaluated.
Event occurred after 2nd vaccine.  12/03/2021: Patient is a 70-year-old male who comes to the emergency department today for shortness of breath.  He states that he began to have mild upper respiratory symptoms 8 days ago on Thanksgiving and on Tuesday he tested positive for Covid.  ( 11/30/2021). He has some mild cough but denies any chest pain.  He also has not been having any vomiting abdominal pain diarrhea or dysuria.
Severe headache, body aches, hot & cold chills symtoms started same eve about 6 hours after injection, then yesterday rash covering body that itches provider prescribed prednisone pak
nauseated; fever; aches; headache; diarrhea; vomiting; This case was reported by a nurse and described the occurrence of nausea in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced nausea, fever, pain, headache, diarrhea and vomiting. On an unknown date, the outcome of the nausea, fever, pain, headache, diarrhea and vomiting were recovered/resolved.   The reporter considered the nausea, fever, pain, headache, diarrhea and vomiting to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The patient received a dose of Shingrix vaccine and on the same day at 11 pm, the p atient experienced nausea, fever, pain, headache, diarrhea and vomiting. The reporter mentioned that, the events were resolved in 2 days. The reporter also mentioned that, the events had occurred because of the vaccine. The reporter consented to follow up.
Patient received immunizations and TB skin test on 8/9/2019 at approximately 12:40pm. Patient stood up and got off the exam table and was standing and talking. Within 4-5 minutes, the nursing staff and parent heard a loud thump. The nurse supervisor turned around and observed the patient laying on the ground. He had fallen and hit the back of his head on the floor. His eyes were open but he did not make any noise. The nurse supervisor picked up the patient and put him on the exam table. An ice pack was put on the back of the patient's head. His pupils were checked as well. Within approximately 1-2 minutes of laying on the table, that patient began to cry. His parent was at his side to provide comfort. The patient was monitored for approximately 15-20 minutes. Cognitively and behaviorally, patient was at his baseline (according to the parent). Nursing staff offered to call EMS, but parent declined. Patient had an appointment following this visit for a physical. Nursing staff strongly encouraged parent follow-up with physician during physical exam regarding incident. Additionally, parent was educated that if patient's behavior changed or he began to exhibit symptoms of a head injury, parent needed to immediately seek medical attention at the hospital. Parent verbalized understanding. A follow up phone call was conducted on 8/14/19 with a gentlemen who identified himself as a friend of the family. He reported patient started school 8/13/19 and was "doing good".
Patient reports that on 4/13/2022 in the morning approximately 7AM she woke up with a fever and her left arm (arm of injection) bisep red and tender to the touch
tested positive for COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, the patient experienced COVID-19 (tested positive for COVID). At the time of the report, COVID-19 (tested positive for COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2021, SARS-CoV-2 test: positive (Positive) tested positive for covid.         No Treatment medications given No Concomitant medication given; Sender's Comments: This is a spontaneous case concerning a female patient of unknown age with no reported medical history, who experienced the non-serious unexpected AESI event of COVID-19. The event occurred on unknown day after the second dose of mRNA-1273 vaccine administration. Causality for the event of COVID-19 was not applicable. The rechallenge was not applicable since the event occurred after the third dose and no further dosing is expected. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Patient reported numbness in his legs with no ability to walk. This continued until the next day. He reports trying to stand up and falling into the wall in front of him. By today (5/16/23) he is able to walk and feels almost back to normal.
Congestion in his chest and some tightness too; Flu like symptoms; Feeling really tired; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Congestion in his chest and some tightness too), INFLUENZA LIKE ILLNESS (Flu like symptoms) and FATIGUE (Feeling really tired) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 006M201A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced CHEST DISCOMFORT (Congestion in his chest and some tightness too), INFLUENZA LIKE ILLNESS (Flu like symptoms) and FATIGUE (Feeling really tired). At the time of the report, CHEST DISCOMFORT (Congestion in his chest and some tightness too), INFLUENZA LIKE ILLNESS (Flu like symptoms) and FATIGUE (Feeling really tired) outcome was unknown. Not Provided          No concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
Fever, severe headache, body aches, injection site soreness, drowsiness . Started when woke up day after vaccine and continued into second day after.